logo
PointFive Unveils Cloud Efficiency Posture Management (CEPM), Transforming How Enterprises Optimize Cloud Resources

PointFive Unveils Cloud Efficiency Posture Management (CEPM), Transforming How Enterprises Optimize Cloud Resources

CEPM offers enterprises a proactive approach to cloud optimization integrated into engineering workflows, and drives immediate savings and long-term efficiency.
NEW YORK, NY / ACCESS Newswire / May 21, 2025 / PointFive, a leading provider of innovative cloud efficiency solutions, announced the launch of Cloud Efficiency Posture Management (CEPM), a new category of cloud optimization technology designed for enterprise engineering and FinOps teams. Inspired by the Cloud Security Posture Management (CSPM), CEPM represents a shift from periodic cost reviews to an always-on, strategic discipline for managing cloud efficiency across an organization.
Traditional cloud cost management tools typically emphasize financial reporting and surface-level optimizations. They neglect deeper technical inefficiencies, resulting in missed opportunities and limited accountability from engineering teams. CEPM addresses this critical gap by proactively detecting hidden cloud waste, providing context, and actionable recommendations.
'We started PointFive to solve cloud inefficiency at its root - the technical, operational reasons - not just surface-level cost management,' said Alon Arvatz, CEO and Founder of PointFive. 'Our new CEPM approach makes cloud efficiency as routine and automatic as cloud security, embedding ongoing optimization deeply into daily engineering processes. This shift is essential for enterprises to realize sustainable efficiency at scale.'
'When we started exploring CEPM across different cloud providers, we were struck by how profoundly each platform's unique metrics influence efficiency,' said Dor Azouri, VP of Research at PointFive. 'Traditional tools overlook this because their focus is surface-level visibility. With DeepWaste™, context is everything. The significant savings we uncovered were eye-opening.'
Key features of CEPM include:
Customers like BHN have successfully streamlined cloud optimization practices through CEPM, fostering deeper engineering engagement and sustained cost efficiencies.
'Cloud optimization should not be a periodic task or reactive exercise,' Arvatz emphasized. 'CEPM empowers engineering teams to continuously embed efficiency into daily operations. The result is sustainable cloud savings, improved reliability, and increased agility - delivering strategic value far beyond simple cost-cutting.'
To learn more about CEPM and how PointFive is redefining cloud optimization, visit www.pointfive.co.
About PointFive
PointFive delivers innovative cloud efficiency solutions for enterprise engineering and FinOps teams. Its Cloud Efficiency Posture Management (CEPM) platform offers deep, actionable insights, continuous optimization, and measurable outcomes, enabling enterprises to proactively manage cloud resources and achieve sustainable efficiency.
Media Contact:
Omri Hurwitz
[email protected]
SOURCE: Pointfive
press release

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Richmond American Set to Build New Jacksonville Community
Richmond American Set to Build New Jacksonville Community

Yahoo

time20 minutes ago

  • Yahoo

Richmond American Set to Build New Jacksonville Community

Laurelton will showcase beautiful homes with open layouts and designer details JACKSONVILLE, Fla., June 3, 2025 /PRNewswire/ -- Richmond American Homes of Florida, LP, a subsidiary of M.D.C. Holdings, Inc., is pleased to announce that it recently purchased and closed on 151 future homesites in Jacksonville. The land is set to become Laurelton, an exciting new master-planned community in Clay County. This notable neighborhood will offer nine inspired floor plans from the builder's popular Seasons™ Collection ( designed to optimize living space and make homeownership more accessible. All homes will showcase professionally curated fixtures and finishes ( "We're excited to welcome Richmond American Homes of Florida to Laurelton," said Noah Breakstone, CEO of BTI Partners, the master developer behind the community. "Our approach has always centered on partnering with respected builders to bring thoughtfully planned neighborhoods to life. Laurelton is more than just new homes - it's about creating spaces where people can connect with nature, their neighbors, and a lifestyle that reflects how they truly want to live." More about Laurelton: New single- and two-story homes from the $400s 9 thoughtfully designed Seasons™ Collection floor plans Generous homesites Designer-curated fixtures and finishes Near St. John's River Close proximity to shopping, dining and prominent employment hubs Community schools, golf course, clubhouse, trails, grocery store and more Call 561.409.1040 or visit for more information. About M.D.C. Holdings, Inc. M.D.C. Holdings, Inc. was founded in 1972. MDC's homebuilding subsidiaries, which operate under the name Richmond American Homes, have helped more than 250,000 homebuyers achieve the American Dream since 1977. One of the largest homebuilders in the nation, MDC is committed to quality and value that is reflected in each home its subsidiaries build. The Richmond American companies have operations in Alabama, Arizona, California, Colorado, Florida, Idaho, Maryland, Nevada, New Mexico, Oregon, Tennessee, Texas, Utah, Virginia and Washington. Mortgage lending, insurance and title services are offered by the following MDC subsidiaries, respectively: HomeAmerican Mortgage Corporation, American Home Insurance Agency, Inc. and American Home Title and Escrow Company. For more information, visit About BTI Partners BTI Partners is one of Florida's leading real estate and land developers. The company is reshaping cities across Florida by master-planning vibrant mixed-use communities, building luxury residential projects in strategic locations, re-activating marinas, and revitalizing neighborhoods with highly amenitized commercial and residential developments in urban areas. Core values of integrity, passion, excellence, selflessness and purpose are central to the company's ethos. Its successful track record has established BTI Partners as an industry leader in creating urban enclaves that attract and sustain local business and family life. By seamlessly integrating residential, commercial, retail, hospitality, entertainment, education, and recreational uses, BTI Partners designs highly desirable 'live, work, play' communities to meet the needs of today and tomorrow. A forward-looking company, BTI Partners remains ever mindful of evolving trends and continuously seeks opportunities to develop transformational and inspirational mixed-use projects through-out the sunbelt states. View original content to download multimedia: SOURCE M.D.C. Holdings, Inc. Sign in to access your portfolio

Establishment Labs to Present at Jefferies Global Healthcare Conference
Establishment Labs to Present at Jefferies Global Healthcare Conference

Yahoo

timean hour ago

  • Yahoo

Establishment Labs to Present at Jefferies Global Healthcare Conference

NEW YORK, June 03, 2025--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in the Jefferies Global Healthcare Conference. Peter Caldini, Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, are scheduled to present in a fireside chat on Wednesday, June 4, 2025 at 7:35 a.m. ET. A live webcast of the presentation will be available on the Establishment Labs investor relations website at Archived versions of the webcasts will be available on the same website following the completion of the events. About Establishment Labs Establishment Labs Holdings Inc. is a global medical device company dedicated to improving women's health and wellness in breast aesthetics and reconstruction through the power of science, engineering, and technology. The Company offers a portfolio of solutions for breast health, breast aesthetics, and breast reconstruction in over 90 countries. With over four million Motiva ® devices delivered to plastic and reconstructive surgeons since 2010, the Company's products have created a new standard for safety and patient satisfaction. The company's minimally invasive platform consists of Mia Femtech®, a unique minimally invasive experience for breast harmonization, and Preservé™, a breast tissue preserving and minimally invasive technology for breast augmentation, revision augmentation and mastopexy augmentation. GEM® is a next generation minimally invasive system for gluteal ergonomic modeling currently undergoing an IRB approved pivotal study. The Motiva Flora® tissue expander is used to improve outcomes in breast reconstruction following breast cancer and is the only regulatory-approved expander in the world with an integrated port using radio-frequency technology that is MRI conditional. Zensor™ is an RFID technology platform used to safely identify implantable devices from outside the body, and includes the company's first biosensor Zen°™, currently part of an IRB approved pivotal study to measure core breast temperature. These solutions are supported by over 200 patent applications in 20 separate patent families worldwide and over 100 scientific and clinical studies and publications in peer reviewed journals. Establishment Labs manufactures at two facilities in Costa Rica compliant with all applicable regulatory standards under ISO13485:2024 and FDA 21 CFR 820. Please visit our website for additional information at View source version on Contacts Investor/Media Contact: Raj Denhoy415 828-1044rdenhoy@ Sign in to access your portfolio

Establishment Labs to Present at Jefferies Global Healthcare Conference
Establishment Labs to Present at Jefferies Global Healthcare Conference

Yahoo

timean hour ago

  • Yahoo

Establishment Labs to Present at Jefferies Global Healthcare Conference

NEW YORK, June 03, 2025--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in the Jefferies Global Healthcare Conference. Peter Caldini, Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, are scheduled to present in a fireside chat on Wednesday, June 4, 2025 at 7:35 a.m. ET. A live webcast of the presentation will be available on the Establishment Labs investor relations website at Archived versions of the webcasts will be available on the same website following the completion of the events. About Establishment Labs Establishment Labs Holdings Inc. is a global medical device company dedicated to improving women's health and wellness in breast aesthetics and reconstruction through the power of science, engineering, and technology. The Company offers a portfolio of solutions for breast health, breast aesthetics, and breast reconstruction in over 90 countries. With over four million Motiva ® devices delivered to plastic and reconstructive surgeons since 2010, the Company's products have created a new standard for safety and patient satisfaction. The company's minimally invasive platform consists of Mia Femtech®, a unique minimally invasive experience for breast harmonization, and Preservé™, a breast tissue preserving and minimally invasive technology for breast augmentation, revision augmentation and mastopexy augmentation. GEM® is a next generation minimally invasive system for gluteal ergonomic modeling currently undergoing an IRB approved pivotal study. The Motiva Flora® tissue expander is used to improve outcomes in breast reconstruction following breast cancer and is the only regulatory-approved expander in the world with an integrated port using radio-frequency technology that is MRI conditional. Zensor™ is an RFID technology platform used to safely identify implantable devices from outside the body, and includes the company's first biosensor Zen°™, currently part of an IRB approved pivotal study to measure core breast temperature. These solutions are supported by over 200 patent applications in 20 separate patent families worldwide and over 100 scientific and clinical studies and publications in peer reviewed journals. Establishment Labs manufactures at two facilities in Costa Rica compliant with all applicable regulatory standards under ISO13485:2024 and FDA 21 CFR 820. Please visit our website for additional information at View source version on Contacts Investor/Media Contact: Raj Denhoy415 828-1044rdenhoy@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store